MISSING: Transparence in Clinical Drug Trials
Whether it’s acne drugs, anxiety drugs, asthma drugs or possible COVID-19 cures, MISSD believes transparency in sharing clinical trial data is necessary to reduce adverse drug effects and related deaths.
Read the full Kaiser Health News article at https://khn.org/news/nih-and-fda-examine-serious-side-effect-that-surfaced-in-covid-vaccine-trial/?utm_campaign=KHN%3A%20Daily%20Health%20Policy%20Report&utm_medium=email&_hsmi=95280749&_hsenc=p2ANqtz-8ZTSOmr_0wNVZFvY8vrjVBkkpxq0mX_zHYe9EYSaAhbUZ2HO-p_r00AxSMfRPBaKOkhNMBnlk1_3L0dYbep2OVM8B_Vw&utm_content=95280749&utm_source=hs_email
